Ketamine should be available for treatment resistant depression, says FDA panel - The BMJ

Submitted by Anonymous (not verified) on Fri, 02/22/2019 - 15:57

Ketamine should be available for treatment resistant depression, says FDA panel  The BMJBMJ 2019; 364 doi: https://doi.org/10.1136/bmj.l858 (Published 22 February 2019) Cite this as: BMJ 2019;364:l858. Article; Related *content*; Metrics; Responses ...